Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02010645. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00253513. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT05483010. IPD Sharing: YES. Countries: 1. Publications: 0.
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03092674. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT02684162. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00445744. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rabbit Anti-thymocyte Globulin in the Treatment of Patients With Low to Intermediate-1 Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00542828. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Participants With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are R
ClinicalTrials.gov study NCT03011034. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT02721875. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease
ClinicalTrials.gov study NCT02370888. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT00067028. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Daratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03067571. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
ClinicalTrials.gov study NCT02201329. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine, Venetoclax, and Trametinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04487106. IPD Sharing: Not stated. Countries: 1. Publications: 0.
APR-548 in Combination With Azacitidine for the Treatment of TP53 Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT04638309. IPD Sharing: NO. Countries: 1. Publications: 0.
Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT05918055. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Oral Decitabine/Cedazuridine in Combination With Magrolimab in Participants With Intermediate- to Very High-Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT05835011. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Pharmacokinetics Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01700335. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients
ClinicalTrials.gov study NCT00382590. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT02281084. IPD Sharing: Not stated. Countries: 10. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.